One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Natural History and Risk Stratification of Recurrent Crohn’s Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study
Vincent Joustra, MD, Marjolijn Duijvestein, MD, PhD, Aart Mookhoek, MD, PhD, Willem Bemelman, MD, PhD, Christianne Buskens, MD, PhD, Matic Koželj, MD, PhD, Gregor Novak, MD, PhD, Pieter Hindryckx, MD, PhD, Nahid Mostafavi, MS, PhD, Geert D’Haens, MD, PhD
doi : 10.1093/ibd/izab044
Serum Analyte Profiles Associated With Crohn’s Disease and Disease Location
Gabrielle Boucher, MSc, Alexandre Paradis, MSc, Geneviève Chabot-Roy, MSc, Lise Coderre, PhD, Erin E Hillhouse, PhD, Alain Bitton, MD, Christine Des Rosiers, PhD, Megan K Levings, PhD, L Philip Schumm, MA, Mark Lazarev, MD, Steve R Brant, MD, Richard Duerr, MD, Dermot McGovern, MD, PhD, Mark S Silverberg, MD, PhD, Judy Cho, MD, Sylvie Lesage, PhD, John D Rioux, PhD, iGenoMed Consortium , NIDDK IBD Genetics Consortium
doi : 10.1093/ibd/izab123
Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease
Kaoru Suzuki, MD, Yoichi Kakuta, MD, PhD, Takeo Naito, MD, PhD, Tetsuya Takagawa, MD, PhD, Hiroyuki Hanai, MD, PhD, Hiroshi Araki, MD, PhD, Yu Sasaki, MD, PhD, Hirotake Sakuraba, MD, PhD, Makoto Sasaki, MD, PhD, Tadakazu Hisamatsu, MD, PhD, Satoshi Motoya, MD, PhD, Takayuki Matsumoto, MD, PhD, Motoyuki Onodera, MD, PhD, Yoh Ishiguro, MD, PhD, Hiroshi Nakase, MD, PhD, Akira Andoh, MD, PhD, Sakiko Hiraoka, MD, PhD, Masaru Shinozaki, MD, PhD, Toshimitsu Fujii, MD, PhD, Takehiko Katsurada, MD, PhD, Taku Kobayashi, MD, PhD, Mikihiro Fujiya, MD, PhD, Takafumi Otsuka, MD, PhD, Naoki Oshima, MD, PhD, Yasuo Suzuki, MD, PhD, Yuichirou Sato, MD, PhD, Ryota Hokari, MD, PhD, Mitsunori Noguchi, MD, PhD, Yuki Ohta, MD, PhD, Minoru Matsuura, MD, PhD, Yosuke Kawai, PhD, Katsushi Tokunaga, PhD, Masao Nagasaki, PhD, Hisaaki Kudo, PhD, Naoko Minegishi, MD, PhD, Daisuke Okamoto, MD, PhD, Yusuke Shimoyama, MD, PhD, Rintaro Moroi, MD, PhD, Masatake Kuroha, MD, PhD, Hisashi Shiga, MD, PhD, Dalin Li, MD, PhD, Dermot P B McGovern, MD, PhD, Yoshitaka Kinouchi, MD, PhD, Atsushi Masamune, MD, PhD, MENDEL study group
doi : 10.1093/ibd/izab004
Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
Carlos Taxonera, MD, PhD, David Olivares, Cristina Alba, MD
doi : 10.1093/ibd/izab011
Re-induction With Intravenous Ustekinumab in Patients With Crohn’s Disease and a Loss of Response to This Therapy
Fernando Bermejo, MD, PhD, Laura Jiménez, PharmD MSc, Alicia Algaba, MSc PhD, Milagros Vela, MD, Guillermo Bastida, MD, PhD, Olga Merino, MD, Alicia López-GarcÃa, MD, Luigi Melcarne, MD, Iago RodrÃguez-Lago, MD, Saioa de la Maza, MD, Abdel Bouhmidi, MD, Manuel Barreiro-de Acosta, MD, PhD, Pilar López-Serrano, MD, PhD, Marta Carrillo-Palau, MD, Francisco Mesonero, MD, Beatriz Orts, MD, Daniel Bonillo, MD, Alicia Granja, MD, Iván Guerra, MD, PhD GETECCU
doi : 10.1093/ibd/izab015
Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study
Rajat Garg, MD, Abdul Mohammed, MD, Amandeep Singh, MD, Miguel Regueiro, MD, Benjamin Click, MD, MS
doi : 10.1093/ibd/izab017
Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities
Abhishek Bhurwal, MD, Carlos D Minacapelli, MD, Anish Patel, MD, Hemant Mutneja, MD, Akshay Goel, MD, Ishani Shah, MD, Vikas Bansal, MBBS, MPH, Bhaumik Brahmbhatt, MBBS, Kiron M Das, MD, PhD
doi : 10.1093/ibd/izab020
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry
Gherardo Tapete, MD, Lorenzo Bertani, MD, Alberto Pieraccini, MD, Erica Nicola Lynch, MD, Martina Giannotta, MD, Riccardo Morganti, PhD, Ivano Biviano, MD, Sara Naldini, MD, Maria Gloria Mumolo, MD, Francesca De Nigris, MD, Francesca Calella, MD, Siro Bagnoli, MD, Moira Minciotti, MD, Simona Maltinti, MSci, Silvia Rentini, MD, Linda Ceccarelli, MD, Paolo Lionetti, MD, Monica Milla, MD, Francesco Costa, MD, PhD
doi : 10.1093/ibd/izab027
Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry
Alyce Anderson, MD, PhD, Cynthia Cherfane, MD, Benjamin Click, MD, Claudia Ramos-Rivers, MD, Ioannis E Koutroubakis, MD, PhD, Jana G Hashash, MD, MSc, Dmitriy Babichenko, PhD, Gong Tang, PhD, Michael Dunn, MD, Arthur Barrie, MD, PhD,Siobhan Proksell, MD, Jeffrey Dueker, MD, MPH, Elyse Johnston, MD, Marc Schwartz, MD, David G Binion, MD
doi : 10.1093/ibd/izab031
Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants
Helene Chiarella-Redfern, MD, MSc, Sangmin Lee, MSc, Bellal Jubran, MD, Nastaran Sharifi, MD, Remo Panaccione, MD, FRCPC, Cora Constantinescu, MD, MSc, FRCPC, Eric I Benchimol, MD, PhD, FRCPC, Cynthia H Seow, MBBS (Hons), MSc, FRACP
doi : 10.1093/ibd/izab033
Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline
Maria Gazouli, PhD, Nikolas Dovrolis, PhD, Marilena M Bourdakou, PhD, Michalis Gizis, MD, Georgios Kokkotis, MD, George Kolios, MD, PhD, Georgios Michalopoulos, MD, PhD, Spyridon Michopoulos, MD, PhD, Ioannis Papaconstantinou, MD, PhD, Maria Tzouvala, MD, PhD, Nikos Viazis, MD, PhD, Vasilleios Xourafas, MD, Eirini Zacharopoulou, MD, PhD, Evanthia Zampeli, MD, PhD, Gerasimos Mantzaris, MD, PhD, George Papatheodoridis, MD, PhD, Giorgos Bamias, MD, PhD
doi : 10.1093/ibd/izab117
Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling
Lingqi Gong, PhD, Jintao Xiao, MD, Jun Yi, PhD, Junbo Xiao, PhD, Fanggen Lu, PhD, Xiaowei Liu, PhD
doi : 10.1093/ibd/izab132
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4
Bruce Weder, PhD, Fabian Schefer, Wouter Tobias van Haaften, MD, PhD, Eleonora Patsenker, PhD, Felix Stickel, MD, Sebastian Mueller, MD, PhD, Senta Hutter, MD, Cordelia Schuler, Katharina Baebler, Yu Wang, PhD, Céline Mamie, Gerard Dijkstra, MD, PhD, Cheryl de Vallière, PhD, Pedro H Imenez Silva, PhD, Carsten A Wagner, MD, Isabelle Frey-Wagner, PhD, Pedro A Ruiz, PhD, Klaus Seuwen, PhD, Gerhard Rogler, MD, PhD, Martin Hausmann, PhD
doi : 10.1093/ibd/izab140
Aging and IBD: A New Challenge for Clinicians and Researchers
Adam S Faye, MD, MS, Jean-Frederic Colombel, MD
doi : 10.1093/ibd/izab039
Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn’s Disease
Hojjatollah Nazari, MSC, Vahid Yaghoubi Naei, MSC, Asieh Heirani Tabasi, MSC, PhD, Abolfazl Badripour, MD, Reza Akbari Asbagh, MD, Mohammad Reza Keramati, MD, Amirsina Sharifi, MD, Behnam Behboudi, MD, Alireza Kazemeini, MD, Maryam Abbasi, MSC, PhD, Amir Keshvari, MD, Seyed Mohsen Ahmadi Tafti, MD
doi : 10.1093/ibd/izab151
Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease
Jennie G David, PhD, Douglas Chute, PhD, Bonney Reed, PhD, Shehzad Saeed, MD, David DeMatteo, JD, PhD, Orhan Atay, MD, Michele Maddux, PhD, Brian Daly, PhD
doi : 10.1093/ibd/izab154
Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders
Rahul S Dalal, MD, Sanchit Gupta, MD, Hannah Goodrick, Jennifer Mitri, Jessica R Allegretti, MD, MPH
doi : 10.1093/ibd/izab156
Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn’s Disease and a Loss of Response to This Therapy
Fernando Bermejo, MD, PhD, Laura Jiménez, PharmD MSc, Alicia Algaba, MSc PhD, Milagros Vela, MD, Guillermo Bastida, MD, PhD, Olga Merino, MD, Alicia López-GarcÃa, MD, Luigi Melcarne, MD, Iago RodrÃguez-Lago, MD, Saioa de la Maza, MD, Abdel Bouhmidi, MD, Manuel Barreiro-de Acosta, MD, PhD, Pilar López-Serrano, MD, PhD, Marta Carrillo-Palau, MD, Francisco Mesonero, MD, Beatriz Orts, MD, Daniel Bonillo, MD, Alicia Granja, MD, Iván Guerra, MD, PhD GETECCU
doi : 10.1093/ibd/izab242
Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report
Rachele Del Sordo, MD, Guido Lupinacci, MD, Giulia Tanzi, MD, Gabrio Bassotti, MD, Vincenzo Villanacci, MD
doi : 10.1093/ibd/izab196
Mucocutaneous Leishmaniasis Associated With Anti-TNF Therapy: A Case Report
T Valdés Delgado, MD, PhD, C RodrÃguez Delgado, MD, M Pérez-Pérez, MD
doi : 10.1093/ibd/izab197
Detection of a Novel Antigen for Crohn’s Disease
Yarong Wei, MM, Wu Yang, PhD, Qiao Mei, PhD
doi : 10.1093/ibd/izab203
Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues
Ellen M S Xerfan, MD, Monica L Andersen, PhD, Jane Tomimori, MD, PhD, Sergio Tufik, MD, PhD, Anamaria S Facina, MD, PhD
doi : 10.1093/ibd/izab208
COVID’s Double Whammy: Drug Discontinuation Flares the Disease While Vaccination Takes the Blame
Anuraag Jena, MD, DM, Shubhra Mishra, MD, DM, Abhirup Chatterjee, MD, Anupam Kumar Singh, MD, DM, Vishal Sharma, MD, DM
doi : 10.1093/ibd/izab211
Gluteal Sinus Presenting as the Initial Symptom in a Patient With Crohn’s Disease
Hong-Zhu Wen, MD, Ze-Hui He, Pei-Han Li, Qiu-Feng Zhao, MD, Yun-Fei Wang, MD, Jiang Lin, MD
doi : 10.1093/ibd/izab213
The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn’s Disease in Pregnancy
Ralley Prentice, MBBS, Emily K Wright, MBBS, PhD, Emma Flanagan, MBBS, PhD, Alyson L Ross, RN, Sally J Bell, MBBS, MD
doi : 10.1093/ibd/izab214
